A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Charles River Laboratories International Inc’s current trading price is -36.00% away from its 52-week high, while its distance from the 52-week low is 63.65%. The stock’s price range for this time frame has been between $91.86 and $234.90. The trading volume of the company’s shares in the Healthcare reached around 2.24 million for the day, which was evidently higher than the average daily volume of 0.99 million over the last three months.
Currently, the stock price of Charles River Laboratories International Inc (CRL) is $150.33. In the most recent trading session, the stock underwent a significant upswing, peaking at $200.0 after opening at $150.33. The stock touched a low of $108.0 before closing at $167.49.
Charles River Laboratories International Inc’s stock has had a tumultuous market performance.
How Financial Performance Impacts Market Capitalization
Charles River Laboratories International Inc (CRL) has experienced a quarterly rise of 30.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.38B and boasts a workforce of 20100 employees.
Decoding Analysts’ Ratings for Charles River Laboratories International Inc
As of right now, 5 analysts are rating Charles River Laboratories International Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 12 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 144.81, with a change in price of -16.60. Similarly, Charles River Laboratories International Inc recorded 1,334,192 in trading volume during the last 100 days, posting a change of -9.94%.
How CRL’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CRL stands at 0.83. Similarly, the long-term debt-to-equity ratio is also 0.83.
CRL Stock Stochastic Average
The raw stochastic average for Charles River Laboratories International Inc over the last 50 days is presently at 34.40%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 10.74%. Further, the company’s Stochastic %K and %D values for the last 20 days were 41.29% and 51.64%, respectively.
CRL Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price decrease of -35.65%. However, over the past six months, we’ve seen a stronger performance of -7.84%. The price of CRL leaped by -5.09% over the last 30 days. And in the last five days, it has fallen by -14.68%.
